Follicular lymphoma physical examination: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Common physical examination findings of follicular lymphoma include [[fever]], [[rash]], [[splenomegaly]], [[Lymphadenopathy| | Common physical examination findings of follicular lymphoma include [[fever]], [[rash]], [[splenomegaly]], [[Lymphadenopathy|peripheral lymphadenopathy]], and [[Lymphadenopathy|central lymphadenopathy]]. | ||
==Physical Examination== | ==Physical Examination== | ||
The following physical examination findings may be present among patients with follicular lymphoma:<ref name="seer">National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref> | The following physical examination findings may be present among patients with follicular lymphoma:<ref name="seer">National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov</ref> |
Revision as of 20:24, 2 September 2015
Follicular lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Follicular lymphoma physical examination On the Web |
American Roentgen Ray Society Images of Follicular lymphoma physical examination |
Risk calculators and risk factors for Follicular lymphoma physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Common physical examination findings of follicular lymphoma include fever, rash, splenomegaly, peripheral lymphadenopathy, and central lymphadenopathy.
Physical Examination
The following physical examination findings may be present among patients with follicular lymphoma:[1]
Temperature
Skin
Neck
Thorax
- Thoracic masses suggestive of central lymphadenopathy
- Chest tenderness
Abdomen
Extremities
- Peripheral lymphadenopathy
- Bone tenderness
References
- ↑ National Cancer Institute. Surveillance, Epidemiology, and End Results Program 2015. http://seer.cancer.gov